Recombinant blood group proteins facilitate the detection of alloantibodies to high‐prevalence antigens and reveal underlying antibodies: results of an international study

Abstract

rBGPs enable the identification of antibodies to high-prevalence antigens without the need for rare RBC reagents, which are often unavailable. Underlying antibodies can be reliably detected and cross-matching results validated, resulting in a more efficient blood supply for immunized patients.